Skip to main content

CORRECTION article

Front. Endocrinol., 30 March 2023
Sec. Reproduction
Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1176102

Corrigendum: C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis

This article is a correction to:

  1. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis

    1. Read original article
Kechong Zhou&#x;Kechong Zhou1†Chao Li&#x;Chao Li2†Tao ChenTao Chen1Xuejun ZhangXuejun Zhang1Baoluo Ma*Baoluo Ma1*
  • 1Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China
  • 2Department of Orthopedics, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China

A Corrigendum on
C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis

by Zhou K, Li C, Chen T, Zhang X and Ma B (2023) 14:1111277. doi: 10.3389/fendo.2023.1111277

Text correction

In the published article, there was an error. There was a mistake in the Abstract. The result of cancer-specific survival (CSS) was displayed as “HR = 1.663, 95%CI = 1.064-2.6, P = 0.026”.

A correction has been made to the Abstract, Paragraph 1. This sentence previously stated:

“[HR = 1.663, 95%CI = 1.064-2.6, P = 0.026]”

The corrected sentence appears below:

“[HR =1.823, 95%CI = 1.19-2.793, P = 0.006]”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: meta-analysis, C-reactive protein, prostate cancer, prognosis, survival, crp

Citation: Zhou K, Li C, Chen T, Zhang X and Ma B (2023) Corrigendum: C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis. Front. Endocrinol. 14:1176102. doi: 10.3389/fendo.2023.1176102

Received: 28 February 2023; Accepted: 17 March 2023;
Published: 30 March 2023.

Edited and Reviewed by:

Yuxuan Song, Peking University People’s Hospital, China

Copyright © 2023 Zhou, Li, Chen, Zhang and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Baoluo Ma, zkc7312976@163.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.